Nobilis TRT Live

Nazione: Regno Unito

Lingua: inglese

Fonte: VMD (Veterinary Medicines Directorate)

Principio attivo:

Avian pneumovirus

Commercializzato da:

Intervet UK Ltd

Codice ATC:

amended)

INN (Nome Internazionale):

Avian pneumovirus

Stato dell'autorizzazione:

Expired

Scheda tecnica

Revised: June 2010
(ATCVet code amended)
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Nobilis TRT live
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION OF PRODUCT
ACTIVE INGREDIENT PER DOSE
Turkey rhinotracheitis (TRT) virus strain BUT 1#8544

10
2.5
TCID
50
.
3.
PHARMACEUTICAL FORM
Lyophilisate for suspension
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Broilers and turkeys from 1 day old.
4.2
INDICATIONS FOR USE SPECIFYING THE TARGET SPECIES
For the active immunisation of turkeys and broilers to reduce clinical
signs of
rhinotracheitis virus infection.
Onset of immunity: 3 weeks after vaccination
Duration of immunity: 6-9 weeks after vaccination.
4.3
CONTRA-INDICATIONS
None
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
A good immune response is reliant on the reaction of an immunogenic
agent
and a fully competent immune system. Immunogenicity of the vaccine
antigen
will
be
reduced
by
poor
storage
or
inappropriate
administration.
Immunocompetence of the animal may be compromised by a variety of
factors
including poor health, nutritional status, genetic factors, concurrent
drug
therapy and stress. Under certain conditions, for example extreme
disease
pressure, fully immune birds may succumb to disease. Therefore,
successful
vaccination may not be synonymous with full protection in the face of
a
disease challenge.
Do not vaccinate unhealthy birds. Sick or weak birds will not develop
adequate
immunity following vaccination.
The vaccine should not be used on sites where TRT has not been
diagnosed
unless challenge is anticipated.
Page 1 of 4
Revised: June 2010
(ATCVet code amended)
The vaccine virus spreads and shows some reversion to virulence on
bird to
bird passage. For these reasons its use is not recommended on
multi-age
sites.
Correct administration is important to ensure optimal initial vaccine
‘take’
4.5
SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
None
ii.
Special precautions to be taken by the person administering the
product
to animals
Wash and disi